What is a stock summary page? Click here for an overview.
Business Description
Xtant Medical Holdings Inc
NAICS : 339112
SIC : 5047
ISIN : US98420P3082
Description
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.18 | |||||
| Equity-to-Asset | 0.46 | |||||
| Debt-to-Equity | 0.82 | |||||
| Debt-to-EBITDA | -4.46 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -1.82 | |||||
| Beneish M-Score | -2.76 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.7 | |||||
| 3-Year EBITDA Growth Rate | -25.3 | |||||
| 3-Year EPS without NRI Growth Rate | -26 | |||||
| 3-Year FCF Growth Rate | -81.7 | |||||
| 3-Year Book Growth Rate | -4.5 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.93 | |||||
| 9-Day RSI | 47.28 | |||||
| 14-Day RSI | 47.02 | |||||
| 3-1 Month Momentum % | 41.63 | |||||
| 6-1 Month Momentum % | -17.71 | |||||
| 12-1 Month Momentum % | -46.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.35 | |||||
| Quick Ratio | 1 | |||||
| Cash Ratio | 0.22 | |||||
| Days Inventory | 292.64 | |||||
| Days Sales Outstanding | 65.12 | |||||
| Days Payable | 55.84 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -16.9 | |||||
| Shareholder Yield % | -24.33 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 58.17 | |||||
| Operating Margin % | -10.3 | |||||
| Net Margin % | -14.03 | |||||
| FCF Margin % | -13.65 | |||||
| ROE % | -35.34 | |||||
| ROA % | -17.32 | |||||
| ROIC % | -16.81 | |||||
| 3-Year ROIIC % | -19.68 | |||||
| ROC (Joel Greenblatt) % | -21.61 | |||||
| ROCE % | -18.18 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.53 | |||||
| PB Ratio | 1.54 | |||||
| Price-to-Tangible-Book | 2.38 | |||||
| EV-to-EBIT | -7.91 | |||||
| EV-to-EBITDA | -12.15 | |||||
| EV-to-Revenue | 0.82 | |||||
| EV-to-FCF | -6.03 | |||||
| Price-to-GF-Value | 0.52 | |||||
| Price-to-Median-PS-Value | 1.04 | |||||
| Price-to-Net-Current-Asset-Value | 3.97 | |||||
| Earnings Yield (Greenblatt) % | -12.64 | |||||
| FCF Yield % | -24.14 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:XTNT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Xtant Medical Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 117.266 | ||
| EPS (TTM) ($) | -0.12 | ||
| Beta | -0.31 | ||
| 3-Year Sharpe Ratio | 0.03 | ||
| 3-Year Sortino Ratio | 0.05 | ||
| Volatility % | 67.72 | ||
| 14-Day RSI | 47.02 | ||
| 14-Day ATR ($) | 0.0567 | ||
| 20-Day SMA ($) | 0.48093 | ||
| 12-1 Month Momentum % | -46.15 | ||
| 52-Week Range ($) | 0.331 - 1.24 | ||
| Shares Outstanding (Mil) | 139.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Xtant Medical Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Xtant Medical Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Xtant Medical Holdings Inc Frequently Asked Questions
What is Xtant Medical Holdings Inc(XTNT)'s stock price today?
The current price of XTNT is $0.48. The 52 week high of XTNT is $1.24 and 52 week low is $0.33.
When is next earnings date of Xtant Medical Holdings Inc(XTNT)?
The next earnings date of Xtant Medical Holdings Inc(XTNT) is 2025-05-15 Est..
Does Xtant Medical Holdings Inc(XTNT) pay dividends? If so, how much?
Xtant Medical Holdings Inc(XTNT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers